|
US6852313B1
(en)
|
1989-10-16 |
2005-02-08 |
Amgen Inc. |
Method of stimulating growth of melanocyte cells by administering stem cell factor
|
|
US7144731B2
(en)
|
1989-10-16 |
2006-12-05 |
Amgen Inc. |
SCF antibody compositions and methods of using the same
|
|
US6207454B1
(en)
|
1989-10-16 |
2001-03-27 |
Amgen Inc. |
Method for enhancing the effciency of gene transfer with stem cell factor (SCF) polypeptide
|
|
US6248319B1
(en)
|
1989-10-16 |
2001-06-19 |
Krisztina M. Zsebo |
Method for increasing hematopoietic progenitor cells by stem cell factor polypeptides
|
|
US5581476A
(en)
|
1993-01-28 |
1996-12-03 |
Amgen Inc. |
Computer-based methods and articles of manufacture for preparing G-CSF analogs
|
|
US6642049B1
(en)
*
|
1998-12-04 |
2003-11-04 |
The United States Of America As Represented By The Secretary Of The Navy |
Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38-bone marrow stem cells
|
|
AU1350801A
(en)
*
|
1999-10-27 |
2001-05-08 |
Frances Arnold |
Production of functional hybrid genes and proteins
|
|
US6346247B1
(en)
|
1999-10-28 |
2002-02-12 |
Promega Corporation |
Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies
|
|
GB0024550D0
(cg-RX-API-DMAC10.html)
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
|
US20030032179A1
(en)
|
2000-12-06 |
2003-02-13 |
Hariri Robert J. |
Post-partum mammalian placenta, its use and placental stem cells therefrom
|
|
US7311905B2
(en)
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
|
EP2206772A3
(en)
|
2000-12-06 |
2010-08-04 |
Robert J. Hariri |
Method of collecting placental stem cells
|
|
KR100961859B1
(ko)
|
2001-07-11 |
2010-06-09 |
맥시겐 홀딩스 엘티디 |
지-씨에스에프 접합체
|
|
US7700090B2
(en)
|
2002-02-13 |
2010-04-20 |
Anthrogenesis Corporation |
Co-culture of placental stem cells and stem cells from a second source
|
|
CN1717177A
(zh)
|
2002-11-26 |
2006-01-04 |
人类起源公司 |
细胞治疗剂、细胞治疗单元及其用于治疗的方法
|
|
BRPI0611221A2
(pt)
|
2005-06-01 |
2010-08-24 |
Maxygen Holdings Ltd |
polipeptÍdeos de g-csf peguilados e mÉtodos de produÇço dos mesmos
|
|
AU2006304277B2
(en)
|
2005-10-13 |
2012-07-05 |
Celularity Inc. |
Immunomodulation using placental stem cells
|
|
KR101900809B1
(ko)
|
2005-12-29 |
2018-09-20 |
안트로제네시스 코포레이션 |
태반 줄기 세포 집단
|
|
EP2687220A3
(en)
|
2007-02-12 |
2014-05-14 |
Anthrogenesis Corporation |
Treatment of inflammatory diseases using placental stem cells
|
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
|
KR20230065354A
(ko)
|
2007-09-28 |
2023-05-11 |
셀룰래리티 인코포레이티드 |
인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법
|
|
EP3539380A3
(en)
|
2008-08-20 |
2019-12-18 |
Celularity, Inc. |
Improved cell composition and methods of making the same
|
|
JP5950577B2
(ja)
|
2008-08-20 |
2016-07-13 |
アンスロジェネシス コーポレーション |
単離胎盤細胞を使用した脳卒中の治療
|
|
ES2426241T3
(es)
|
2008-08-22 |
2013-10-22 |
Anthrogenesis Corporation |
Métodos y composiciones para el tratamiento de defectos óseos con poblaciones de células placentarias
|
|
WO2010059828A1
(en)
|
2008-11-19 |
2010-05-27 |
Anthrogenesis Corporation |
Amnion derived adherent cells
|
|
MX353489B
(es)
|
2009-07-02 |
2018-01-16 |
Anthrogenesis Corp |
Metodo para producir eritrocitos sin celulas alimentadoras.
|
|
EP2454363B1
(en)
*
|
2009-07-13 |
2020-07-22 |
Biogencell, Ltd. |
Method for using directing cells for specific stem/progenitor cell activation and differentiation
|
|
AU2011209819A1
(en)
|
2010-01-26 |
2012-08-16 |
Anthrogenesis Corporation |
Treatment of bone-related cancers using placental stem cells
|
|
TW202011974A
(zh)
|
2010-04-07 |
2020-04-01 |
美商安瑟吉納西斯公司 |
利用胎盤幹細胞之血管新生
|
|
JP2013523823A
(ja)
|
2010-04-08 |
2013-06-17 |
アントフロゲネシス コーポレーション |
胎盤幹細胞を用いるサルコイドーシスの治療
|
|
AU2011279201B2
(en)
|
2010-07-13 |
2016-01-21 |
Celularity Inc. |
Methods of generating natural killer cells
|
|
AR093183A1
(es)
|
2010-12-31 |
2015-05-27 |
Anthrogenesis Corp |
Aumento de la potencia de celulas madre de placenta usando moleculas de arn moduladoras
|
|
AU2012262273B2
(en)
|
2011-06-01 |
2017-09-14 |
Celularity Inc. |
Treatment of pain using placental stem cells
|
|
WO2013055476A1
(en)
|
2011-09-09 |
2013-04-18 |
Anthrogenesis Corporation |
Treatment of amyotrophic lateral sclerosis using placental stem cells
|
|
US8956870B2
(en)
|
2012-01-19 |
2015-02-17 |
Biogencell, Ltd. |
Method for using directing cells for specific stem/progenitor cell activation and differentiation
|
|
CA2869674A1
(en)
|
2012-06-08 |
2013-12-12 |
Alkermes, Inc. |
Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
|
|
US9763983B2
(en)
|
2013-02-05 |
2017-09-19 |
Anthrogenesis Corporation |
Natural killer cells from placenta
|
|
WO2023145860A1
(ja)
*
|
2022-01-27 |
2023-08-03 |
味の素株式会社 |
Ｓｃｆ受容体結合ペプチド
|